{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:28:33Z","timestamp":1794724113096,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.diagmicrobio.2026.117691","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:20:49Z","timestamp":1791588049000},"page":"117691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discordance without error: why antimicrobial susceptibility testing methods give different results and which result should we report?"],"prefix":"10.1016","volume":"117","author":[{"given":"Sibin","family":"P\u2024S\u2024","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Harib Al","family":"Sumri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimmy","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lailah Pangal","family":"Darping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0001","article-title":"Antimicrobial susceptibility test methods: dilution and disk diffusion methods","author":"Koeth","year":"2023","journal-title":"Clin Micro Now"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117691_bib0002","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0003","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/9781555816728.ch68","article-title":"Susceptibility test methods: dilution and disk diffusion methods","author":"Patel","year":"2011","journal-title":"Man Clin Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117691_bib0004","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1089\/mdr.2020.0011","article-title":"Comparison of antimicrobial susceptibility test results of disk diffusion, gradient strip, and automated dilution with broth microdilution for piperacillin-tazobactam","volume":"27","author":"Gehring","year":"2021","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0005","series-title":"CLSI supplement M100","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2026"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0006","series-title":"CLSI standard M07","article-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2024"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0007","series-title":"Clinical breakpoint tables for interpretation of MICs and zone diameters, version 16.1","year":"2026"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0008","year":"2019","journal-title":"ISO 20776-1:2019"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0009","series-title":"CLSI standard M02","article-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests","year":"2024"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0010","series-title":"EUCAST disk diffusion method manual, version 13.0 (January 2025), and routine and extended internal quality control tables","year":"2026"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0011","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Definition of S, I and R (2019); ATU\u2014the Area of Technical Uncertainty: Guidance to laboratories on how to deal with the ATU in antimicrobial susceptibility testing (updated 8 February 2024). EUCAST; online resources accessed 4 September 2026."},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0012","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0013","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","article-title":"The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification","volume":"4","author":"Nicoloff","year":"2019","journal-title":"Nat Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117691_bib0014","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/jac\/dkz226","article-title":"Inoculum effect of beta-lactam antibiotics","volume":"74","author":"Lenhard","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117691_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cmi.2017.11.020","article-title":"Antimicrobial susceptibility testing of colistin: evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp","volume":"24","author":"Matuschek","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117691_bib0016","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117691_bib0017","doi-asserted-by":"crossref","first-page":"1156.e1","DOI":"10.1016\/j.cmi.2022.04.013","article-title":"Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales","volume":"28","author":"Bonnin","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117691_bib0018","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/jac\/dkac080","article-title":"Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing","volume":"77","author":"Matuschek","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117691_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the Achilles' heel of the Trojan horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117691_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00276-21","article-title":"EUCAST Steering Committee. Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)","volume":"60","author":"Giske","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117691_bib0021","doi-asserted-by":"crossref","first-page":"1685.e1","DOI":"10.1016\/j.cmi.2020.02.038","article-title":"Area of technical uncertainty for susceptibility testing of amoxicillin\/clavulanate against Escherichia coli: analysis of automated system, Etest and disk diffusion methods compared to the broth microdilution reference","volume":"26","author":"Soares","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117691_bib0022","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/AAC.01406-06","article-title":"Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains","volume":"51","author":"Lo-Ten-Foe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0023","series-title":"CLSI guideline M52","article-title":"Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0024","unstructured":"Clinical and Laboratory Standards Institute. Breakpoint Implementation Toolkit (BIT). CLSI\/APHL\/ASM\/CAP\/CDC; updated March 2026."},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117691_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01255-25","volume":"64","author":"Lin","year":"2026","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0026","first-page":"1","article-title":"Cefiderocol susceptibility in carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia isolates: concordance of disk diffusion with the reference method and comparative analysis of CLSI-EUCAST criteria","author":"Saylam","year":"2026","journal-title":"J Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117691_bib0027","doi-asserted-by":"crossref","first-page":"788.e1","DOI":"10.1016\/j.cmi.2020.11.012","article-title":"Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusion","volume":"27","author":"Wootton","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117691_bib0028","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.diagmicrobio.2016.08.015","article-title":"In vitro susceptibility of Burkholderia cepacia complex isolates: comparison of disk diffusion, Etest, agar dilution, and broth microdilution methods","volume":"86","author":"Fehlberg","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117691_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00843-21","article-title":"Antimicrobial susceptibility testing for enterococci","volume":"60","author":"Khan","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117691_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117691_bib0031","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cmi.2018.05.021","article-title":"The quality of antimicrobial discs from nine manufacturers\u2014EUCAST evaluations in 2014 and 2017","volume":"25","author":"\u00c5hman","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117691_bib0032","doi-asserted-by":"crossref","first-page":"1412.e1","DOI":"10.1016\/j.cmi.2020.01.018","article-title":"EUCAST evaluation of 21 brands of Mueller\u2013Hinton dehydrated media for disc diffusion testing","volume":"26","author":"\u00c5hman","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117691_bib0033","doi-asserted-by":"crossref","first-page":"1499.e1","DOI":"10.1016\/j.cmi.2022.05.030","article-title":"Evaluation of ten brands of pre-poured Mueller\u2013Hinton agar plates for EUCAST disc diffusion testing","volume":"28","author":"\u00c5hman","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2026.117691_bib0034","series-title":"CLSI guideline M23","article-title":"Development of In Vitro Susceptibility Test Methods, Breakpoints, and Quality Control Parameters","year":"2023"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326004426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326004426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:43:52Z","timestamp":1794721432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326004426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0732889326004426"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117691","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordance without error: why antimicrobial susceptibility testing methods give different results and which result should we report?","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117691"}}